Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 4 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Shuttle Pharmaceuticals Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 4 filings
- 1 insider, $181.8K in total
- Open-market sells
- 3 filings
- 1 insider, $504.8K in total
- Insiders trading
- 1
- Net value
- −$323.1K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Shuttle Pharmaceuticals Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| HRT Financial LP | 10% Owner | 0 | Jul 15, 2026 | 6 |
| Richards Steven M | Director | 1,707 | Aug 13, 2025 | 0 |
| Lorber Timothy J. | Chief Financial Officer | – | Aug 12, 2025 | 0 |
| Scorsis George | Director | – | Aug 12, 2025 | 0 |
| Nabyt Oleh | Director | – | Aug 12, 2025 | 0 |
| Tung Joseph | Director | – | Aug 12, 2025 | 0 |
| Jung Mira | Chief Scientific Officer | 135,715 | Oct 9, 2024 | 0 |
| Senanayake Chris | Director | 2,791 | Mar 14, 2024 | 0 |
| Vander Hoek Michael | Chief Financial Officer | 103,852 | Mar 8, 2024 | 0 |
| Brown Milton | Director | 1,094,610 | Jan 2, 2024 | 0 |
| Jacobs Bette | Director | 27,064 | Dec 20, 2023 | 0 |
| Dritschilo Anatoly | CEO and Chairman | 2,100,000Indirect | Aug 18, 2023 | 0 |
| Adkins William | Other: Former Director | 184,071 | Jan 4, 2023 | 0 |
| Rich Tyvin | Chief Medical Officer | 2,429 | Jan 3, 2023 | 0 |
| Dritschilo Peter | President and COO | 6,560 | Dec 30, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 (view filing)3:36 PM ET | Jul 13-14 | 2 days | HRT Financial LP10% Owner | SSale | −83.1K | $4.48 | −$372.7K | −100.0%0 after | 2 lots |
| Jul 13, 2026 (view filing)2:34 PM ET | Jul 9-10 | 4 days | HRT Financial LP10% Owner | PPurchase | +9.00K | $3.36 | +$30.2K | +17.2%61.3K after | 2 lots |
| Jul 9, 2026 (view filing)5:50 PM ET | Jul 7-8 | 2 days | HRT Financial LP10% Owner | SSale | −29.1K | $3.45 | −$100.5K | −35.8%52.3K after | 2 lots |
| Jul 7, 2026 (view filing)4:23 PM ET | Jul 2 | 5 days | HRT Financial LP10% Owner | PPurchase | +7.85K | $3.54 | +$27.8K | +9.5%90.4K after | |
| Jul 7, 2026 (view filing)4:23 PM ET | Jul 6 | 1 day | HRT Financial LP10% Owner | SSale | −9.02K | $3.51 | −$31.7K | −10.0%81.4K after | |
| Jul 2, 2026 (view filing)1:37 PM ET | Jul 1 | 1 day | HRT Financial LP10% Owner | PPurchase | +3.96K | $3.30 | +$13.1K | +5.0%82.6K after | |
| Jul 1, 2026 (view filing)7:17 PM ET | Jun 29-30 | 2 days | HRT Financial LP10% Owner | PPurchase | +32.6K | $3.40 | +$110.7K | +70.8%78.6K after | 2 lots |
| Mar 14, 2024 (view filing) | Dec 29, 2022 | 441 daysLate | Senanayake ChrisDirector | SSale | −1.63K | $1.61 | −$2.62K | −36.8%2.79K after | |
| Jan 2, 2024 (view filing)5:10 PM ET | Dec 13, 2023 | 20 daysLate | Brown MiltonDirector | SSale | −2.92K | $0.4632 | −$1.35K | −0.3%1.09M after | |
| Dec 20, 2023 (view filing)9:51 PM ET | Dec 13 | 7 daysLate | Jacobs BetteDirector | SSale | −4.16K | $0.4632 | −$1.93K | −13.3%27.1K after | |
| Jan 9, 2023 (view filing) | Dec 29, 2022 | 11 daysLate | Richards Steven MDirector | SSale | −995 | $1.61 | −$1.60K | −36.8%1.71K after | |
| Jan 4, 2023 (view filing) | Dec 29, 2022 | 6 daysLate | Adkins WilliamOther: Former Director | SSale | −995 | $1.61 | −$1.60K | −0.5%184.1K after | |
| Jan 4, 2023 (view filing) | Dec 29, 2022 | 6 daysLate | Brown MiltonDirector | SSale | −995 | $1.61 | −$1.60K | −0.1%1.07M after | |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Dritschilo AnatolyCEO and Chairman | SSale | −8.37K | $1.61 | −$13.5K | −0.8%1.09M after | |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Rich TyvinChief Medical Officer | SSale | −1.41K | $1.61 | −$2.28K | −36.8%2.43K after | |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Jung MiraChief Scientific Officer | SSaleCLASS A COMMON STOCK | −328 | $1.61 | −$528.08 | 0.0%1.07M after | |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Jacobs BetteDirector | SSaleCLASS A COMMON STOCK | −4.37K | $1.61 | −$7.03K | −12.3%31.2K after | |
| Dec 30, 2022 (view filing) | Dec 29 | 1 day | Dritschilo PeterPresident and COO | SSale | −3.82K | $1.61 | −$6.15K | −36.8%6.56K after | |
| Dec 30, 2022 (view filing) | Dec 29 | 1 day | Vander Hoek MichaelChief Financial Officer | SSale | −2.24K | $1.61 | −$3.61K | −36.8%3.85K after |